Anemia and diabetic nephropathy.
Anemia has recently been recognized as a frequent complication of diabetic nephropathy, appearing earlier than in nondiabetic renal disease and amplifying the risks of cardiovascular and microvascular complications. A major cause is an inappropriate erythropoietin response to anemia, often accompanied by iron deficiency and therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Ritz
Eberhard
E
Nierenzentrum, Medizinische Universitätsklinik Heidelberg, Im Neuemheimer Feld 162, D-69120 Heidelberg, Germany. prof.e.ritz@t-online.de
D000740:Anemia / Q000209:etiology*; D003925:Diabetic Angiopathies / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000503:physiopathology*; D003929:Diabetic Neuropathies / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000503:physiopathology; D018450:Disease Progression; D004921:Erythropoietin / Q000172:deficiency / Q000502:physiology; D006331:Heart Diseases / Q000503:physiopathology; D006801:Humans
D004921:Erythropoietin